A Failed Cholesterol Drug Raises the Stakes for Amgen (AMGN) and Eli Lilly (LLY) Too

18 9 月, 2026

One Min Read

9 Views

原文: https://finance.yahoo.com/healthcare/articles/failed-cholesterol-drug-raises-stakes-235724249.html

Last Update: 18 9 月, 2026

Written By

Other Articles

Previous

北水增持商湯-W 減持北控水務集團

Next

Novartis (NVS) Suffers its Third Drug Trial Setback in a Week, and its Worst Trading Day in Years

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

Prequalified vs. preapproved credit card offers: What’s the difference?

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept